Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Koerbel, Kimberly; Yalachkov, Yavor; Rotter, Tabea et al.
Exploring the Link Between Renal Function Fluctuations Within the Physiological Range and Serum/CSF Levels of NfL, GFAP, tTAU, and UCHL1INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 26. H. 2. 2025
Thomas, Simone; Wermke, Martin; Vucinic, Vladan et al.
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsCANCERS. Bd. 17. H. 18. 2025
Lopetuso, Loris R.; Deleu, Sara; Puca, Pierluigi et al.
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus ConferenceINFLAMMATORY BOWEL DISEASES. 2025 S. 12
Clausen, Bjoern E.; Dudziak, Diana
Guidelines and Advances in Basic and Applied Dendritic Cell BiologyEUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 55. H. 4. 2025
Borges-Canha, Marta; Centelles-Lodeiro, Javier; Leite, Ana Rita et al.
Gut dysbiosis is linked to severe steatosis and enhances its diagnostic performance in MASLDEGASTROENTEROLOGY. Bd. 3. H. 3. 2025
Mikulicic, Snjezana; Massenberg, Annika; Doering, Tatjana et al.
HSPG-binding peptide Pep19-2.5 is a potent inhibitor of HPV16 infectionANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Bd. 69. H. 2. 2025
Southern, Rebecca M.; Schmitz, Rebecca L.; Samaniego-Castruita, Daniela et al.
IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomasSCIENCE ADVANCES. Bd. 11. H. 35. 2025
Denk, Dominic; Ramakrishnan, Mallika; Conche, Claire et al.
IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesisIMMUNITY. Bd. 58. H. 3. 2025 S. 701-715
Cocciardi, Sibylle; Saadati, Maral; Weiss, Nina et al.
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLHEMASPHERE. Bd. 9. H. 1. 2025
Piekarska, Agnieszka; Abouqateb, Mouad; Boreland, William et al.
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working PartyBONE MARROW TRANSPLANTATION. Bd. 60. H. 12. 2025 S. 1574-1583